Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > Quit calling Claritas an investment
View:
Post by Kobedog1 on Sep 10, 2021 9:22am

Quit calling Claritas an investment

This is a purely speculative play. This is not  investing.
Comment by PTBailey on Sep 10, 2021 10:08am
I agree, pretty much all stocks at this price level and companies at this development level are speculative. Even Google and Amazon were speculative at one time.
Comment by Raiders11 on Sep 10, 2021 4:21pm
Kobedog you must be a rocket surgeon figuring that out,any tsxv stock is a gamble not an investment,that's why I laugh on another site of all the posts bragging that they made millions buying penny stocks.
Comment by PTBailey on Sep 11, 2021 12:41pm
Exactly.